{"id":"https://openalex.org/W3084056725","doi":"https://doi.org/10.1007/s40615-020-00853-0","title":"Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers","display_name":"Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers","publication_year":2020,"publication_date":"2020-09-08","ids":{"openalex":"https://openalex.org/W3084056725","doi":"https://doi.org/10.1007/s40615-020-00853-0","mag":"3084056725","pmid":"https://pubmed.ncbi.nlm.nih.gov/32901433","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7478439"},"language":"en","primary_location":{"id":"doi:10.1007/s40615-020-00853-0","doi":"https://doi.org/10.1007/s40615-020-00853-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40615-020-00853-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40615-020-00853-0.pdf","source":{"id":"https://openalex.org/S2765040861","display_name":"Journal of Racial and Ethnic Health Disparities","issn_l":"2196-8837","issn":["2196-8837","2197-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Racial and Ethnic Health Disparities","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s40615-020-00853-0.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074830972","display_name":"Rangaprasad Sarangarajan","orcid":"https://orcid.org/0000-0001-9403-9421","observed_orcids":["https://orcid.org/0000-0001-9403-9421"]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rangaprasad Sarangarajan","raw_affiliation_strings":["BERG LLC, 500 Old Connecticut Path, Bldg B, 3r Floor, Framingham, MA, 01701, USA. Rangaprasad.Sarangarajan@BergHealth.com","BERG LLC, 500 Old Connecticut Path, Bldg B, 3r Floor, Framingham, MA, 01701, USA"],"raw_orcid":"https://orcid.org/0000-0001-9403-9421","affiliations":[{"raw_affiliation_string":"BERG LLC, 500 Old Connecticut Path, Bldg B, 3r Floor, Framingham, MA, 01701, USA. Rangaprasad.Sarangarajan@BergHealth.com","institution_ids":["https://openalex.org/I4210123108"]},{"raw_affiliation_string":"BERG LLC, 500 Old Connecticut Path, Bldg B, 3r Floor, Framingham, MA, 01701, USA","institution_ids":["https://openalex.org/I4210123108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009183159","display_name":"Robert A. Winn","orcid":"https://orcid.org/0000-0001-5948-9291","observed_orcids":["https://orcid.org/0000-0001-5948-9291"]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4390039382","display_name":"VCU Massey Comprehensive Cancer Center","ror":"https://ror.org/0173y3036","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184840846","https://openalex.org/I4390039382"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Winn","raw_affiliation_strings":["Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, 23298, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, 23298, USA","institution_ids":["https://openalex.org/I184840846","https://openalex.org/I4390039382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008685777","display_name":"Michael A. Kiebish","orcid":"https://orcid.org/0000-0002-5678-0072","observed_orcids":["https://orcid.org/0000-0002-5678-0072"]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A. Kiebish","raw_affiliation_strings":["BERG LLC, 500 Old Connecticut Path, Bldg B, 3r Floor, Framingham, MA, 01701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BERG LLC, 500 Old Connecticut Path, Bldg B, 3r Floor, Framingham, MA, 01701, USA","institution_ids":["https://openalex.org/I4210123108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021778616","display_name":"C. Bountra","orcid":"https://orcid.org/0000-0001-6596-153X","observed_orcids":["https://orcid.org/0000-0001-6596-153X"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Chas Bountra","raw_affiliation_strings":["Center for Medicines Discovery, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX37DQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Medicines Discovery, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX37DQ, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079216750","display_name":"Elder Granger","orcid":"https://orcid.org/0000-0002-3643-9547","observed_orcids":["https://orcid.org/0000-0002-3643-9547"]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elder Granger","raw_affiliation_strings":["BERG LLC, 500 Old Connecticut Path, Bldg B, 3r Floor, Framingham, MA, 01701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BERG LLC, 500 Old Connecticut Path, Bldg B, 3r Floor, Framingham, MA, 01701, USA","institution_ids":["https://openalex.org/I4210123108"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058081424","display_name":"Niven R. Narain","orcid":"https://orcid.org/0000-0001-6769-1748","observed_orcids":["https://orcid.org/0000-0001-6769-1748"]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Niven R. Narain","raw_affiliation_strings":["BERG LLC, 500 Old Connecticut Path, Bldg B, 3r Floor, Framingham, MA, 01701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BERG LLC, 500 Old Connecticut Path, Bldg B, 3r Floor, Framingham, MA, 01701, USA","institution_ids":["https://openalex.org/I4210123108"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5074830972"],"corresponding_institution_ids":["https://openalex.org/I4210123108"],"apc_list":{"value":3860,"currency":"USD","value_usd":3860},"apc_paid":{"value":3860,"currency":"USD","value_usd":3860},"fwci":6.0747,"has_fulltext":true,"cited_by_count":52,"citation_normalized_percentile":{"value":0.97646613,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"8","issue":"4","first_page":"973","last_page":"980"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9253000020980835,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9253000020980835,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.03579999879002571,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.01360000018030405,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ace-insertion-deletion-polymorphism","display_name":"ACE I/D polymorphism","score":0.8199999928474426},{"id":"https://openalex.org/keywords/ace-d-allele","display_name":"ACE D allele","score":0.5899999737739563},{"id":"https://openalex.org/keywords/covid-19-risk","display_name":"COVID-19 risk","score":0.9580000042915344},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.6930000185966492},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9950000047683716},{"id":"https://openalex.org/keywords/angiotensin-ii","display_name":"angiotensin II","score":0.8270000219345093},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.6100000143051147},{"id":"https://openalex.org/keywords/allele-frequency","display_name":"allele frequency","score":0.4480000138282776},{"id":"https://openalex.org/keywords/ethnic-differences","display_name":"ethnic differences","score":0.7289999723434448},{"id":"https://openalex.org/keywords/non-hispanic-black-population","display_name":"non-Hispanic Black population","score":0.7170000076293945},{"id":"https://openalex.org/keywords/covid-19-severity","display_name":"COVID-19 severity","score":0.7070000171661377},{"id":"https://openalex.org/keywords/genetic-susceptibility","display_name":"genetic susceptibility","score":0.46700000762939453}],"concepts":[{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.739395022392273},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6138025522232056},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5569265484809875},{"id":"https://openalex.org/C37463918","wikidata":"https://www.wikidata.org/wiki/Q387981","display_name":"Allele frequency","level":4,"score":0.5314380526542664},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5081491470336914},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.41814088821411133},{"id":"https://openalex.org/C2779611605","wikidata":"https://www.wikidata.org/wiki/Q288280","display_name":"ACE inhibitor","level":4,"score":0.4166218638420105},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4150097668170929},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.3905203342437744},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33085301518440247},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21895432472229004},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.17591184377670288},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.16703853011131287},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07353001832962036},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000208","qualifier_name":"ethnology","is_major_topic":true},{"descriptor_ui":"D000093485","descriptor_name":"COVID-19 Drug Treatment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005006","descriptor_name":"Ethnicity","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007703","descriptor_name":"Peptidyl-Dipeptidase A","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D011110","descriptor_name":"Polymorphism, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020022","descriptor_name":"Genetic Predisposition to Disease","qualifier_ui":"Q000208","qualifier_name":"ethnology","is_major_topic":true},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1007/s40615-020-00853-0","doi":"https://doi.org/10.1007/s40615-020-00853-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40615-020-00853-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40615-020-00853-0.pdf","source":{"id":"https://openalex.org/S2765040861","display_name":"Journal of Racial and Ethnic Health Disparities","issn_l":"2196-8837","issn":["2196-8837","2197-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Racial and Ethnic Health Disparities","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7478439","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7478439","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Racial Ethn Health Disparities","raw_type":"Text"},{"id":"pmid:32901433","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32901433","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of racial and ethnic health disparities","raw_type":"Journal Article"},{"id":"pmh:oai:ora.ox.ac.uk:uuid:d37fd333-83b9-42e6-a9c3-87cf582fc276","doi":null,"is_oa":false,"landing_page_url":"https://ora.ox.ac.uk/objects/uuid:d37fd333-83b9-42e6-a9c3-87cf582fc276/files/rwm117r140","pdf_url":null,"source":{"id":"https://openalex.org/S4306402636","display_name":"Oxford University Research Archive (ORA) (University of Oxford)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I40120149","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/I40120149"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OpenAlex","raw_type":"Journal article"}],"best_oa_location":{"id":"doi:10.1007/s40615-020-00853-0","doi":"https://doi.org/10.1007/s40615-020-00853-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40615-020-00853-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40615-020-00853-0.pdf","source":{"id":"https://openalex.org/S2765040861","display_name":"Journal of Racial and Ethnic Health Disparities","issn_l":"2196-8837","issn":["2196-8837","2197-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Racial and Ethnic Health Disparities","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1463819463","display_name":"A UK Hub to Catalyse Open Target Discovery.","funder_award_id":"106169/Z/14/Z","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"}],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3084056725.pdf","grobid_xml":"https://content.openalex.org/works/W3084056725.grobid-xml"},"referenced_works_count":66,"referenced_works":["https://openalex.org/W1539754353","https://openalex.org/W1574872656","https://openalex.org/W1964982019","https://openalex.org/W1969305505","https://openalex.org/W1970508051","https://openalex.org/W1970709580","https://openalex.org/W1978998472","https://openalex.org/W1991926280","https://openalex.org/W2000040025","https://openalex.org/W2001104453","https://openalex.org/W2001204614","https://openalex.org/W2014491720","https://openalex.org/W2021345753","https://openalex.org/W2027259512","https://openalex.org/W2028522071","https://openalex.org/W2047033983","https://openalex.org/W2053369894","https://openalex.org/W2054099227","https://openalex.org/W2063299162","https://openalex.org/W2076653690","https://openalex.org/W2078084723","https://openalex.org/W2097532633","https://openalex.org/W2097805169","https://openalex.org/W2108743785","https://openalex.org/W2111202889","https://openalex.org/W2113969411","https://openalex.org/W2117952349","https://openalex.org/W2123049364","https://openalex.org/W2123826799","https://openalex.org/W2129366803","https://openalex.org/W2136413073","https://openalex.org/W2139477845","https://openalex.org/W2143703701","https://openalex.org/W2148802014","https://openalex.org/W2160670907","https://openalex.org/W2161399617","https://openalex.org/W2167384912","https://openalex.org/W2171671715","https://openalex.org/W2313849677","https://openalex.org/W2323072331","https://openalex.org/W2337855427","https://openalex.org/W2410159512","https://openalex.org/W2410545784","https://openalex.org/W2416002445","https://openalex.org/W2470654395","https://openalex.org/W2519778034","https://openalex.org/W2753321278","https://openalex.org/W2807625224","https://openalex.org/W2893804275","https://openalex.org/W3009912996","https://openalex.org/W3011605790","https://openalex.org/W3012699877","https://openalex.org/W3013591571","https://openalex.org/W3014090262","https://openalex.org/W3014199470","https://openalex.org/W3014504275","https://openalex.org/W3014571869","https://openalex.org/W3014637709","https://openalex.org/W3014784601","https://openalex.org/W3016572296","https://openalex.org/W3016670712","https://openalex.org/W3025527425","https://openalex.org/W3026685590","https://openalex.org/W3128500325","https://openalex.org/W4238920409","https://openalex.org/W4243107327"],"related_works":["https://openalex.org/W3208471204","https://openalex.org/W4311192163","https://openalex.org/W4293196438","https://openalex.org/W4389075240","https://openalex.org/W3201582412","https://openalex.org/W3165593812","https://openalex.org/W4406158918","https://openalex.org/W4387981731","https://openalex.org/W3194139450","https://openalex.org/W4390194561"],"abstract_inverted_index":{"RATIONALE:":[0],"Hypertension,":[1],"obesity":[2],"and":[3,27,58,69,84,94,161,182,197,218],"diabetes":[4],"are":[5],"major":[6],"risk":[7,90],"factors":[8],"associated":[9,53,78],"with":[10,54,79,179,206],"morbidities":[11,217],"underlying":[12],"COVID-19":[13,25,30,92,113,186,207,216,235],"infections.":[14],"Regression":[15],"analysis":[16],"correlated":[17,32],"presence":[18,201],"of":[19,36,108,120,137,146,152,169,190,202,215,224,234,242],"ACE":[20,49,57,73,109,140,153,170,203,225],"insertion/deletion":[21],"(I/D)":[22],"polymorphism":[23,42,51,75,111,205,227],"to":[24,33,100,112,122,244],"incidence":[26],"mortality.":[28],"Furthermore,":[29],"prevalence":[31,107,223],"allele":[34,155,172],"frequency":[35,136,151,168],"angiotensin-converting":[37],"enzyme":[38],"(ACE)":[39],"deletion":[40,50,110],"(D)":[41],"within":[43],"the":[44,165,167,232,240],"European":[45],"population.":[46],"OBJECTIVE:":[47],"Homozygous":[48],"is":[52,76],"increase":[55,193],"in":[56,66,158,175,230],"angiotensin":[59],"II":[60],"(Ang-II),":[61],"sustained":[62],"levels":[63],"can":[64,192,228],"result":[65],"inflammation,":[67],"fibrosis":[68],"organ":[70],"damage.":[71],"The":[72,96,128,200],"DD":[74,204,226],"also":[77],"hypertension,":[80],"acute":[81],"respiratory":[82],"distress":[83],"diabetic":[85],"nephropathy,":[86],"all":[87],"considered":[88],"high":[89],"for":[91,117,135,239],"infection":[93,208],"outcomes.":[95,124,220,246],"study":[97],"objective":[98],"was":[99,133,156,173],"describe":[101],"a":[102,144],"biological":[103],"framework":[104],"associating":[105],"ethnic":[106,222],"comorbidities":[114],"providing":[115,237],"rationale":[116,238],"therapeutic":[118],"utility":[119],"ACE-I/ARBs":[121,243],"improve":[123,245],"METHOD":[125],"AND":[126],"RESULTS:":[127],"Allele":[129],"Frequency":[130],"Database":[131],"(ALFRED)":[132],"queried":[134],"rs4646994":[138],"representing":[139],"I/D":[141],"polymorphism.":[142],"In":[143,164],"total":[145],"349":[147],"worldwide":[148],"population":[149],"samples,":[150],"D":[154,171],"higher":[157,174],"European,":[159],"Asian,":[160],"Africans":[162],"cohorts.":[163],"USA,":[166],"non-Hispanic":[176,180],"Black":[177],"compared":[178],"White":[181],"Mexican":[183],"Americans.":[184],"CONCLUSION:":[185],"binding":[187],"mediated":[188],"reduction/inactivation":[189],"ACE-II":[191],"ACE/Ang-II":[194,211],"signalling":[195],"pathway":[196],"related":[198],"pathologies.":[199],"likely":[209],"augments":[210],"activities,":[212],"increasing":[213],"severity":[214,233],"impacts":[219],"Thus,":[221],"explain":[229],"part":[231],"morbidity":[236],"use":[241]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":12}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-09-14T00:00:00"}